JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Anoikis and Mitophagy-Related Gene Signature for Predicting the Survival and Tumor Cell Progression in Colon Cancer

  • 0Beijing Chao-Yang Hospital, Capital Medical University.
Critical Reviews in Immunology +

|

November 29, 2024

|

November 29, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study identifies key genes related to anoikis and mitophagy for predicting colon cancer survival. Downregulating SPHK1 shows potential in reducing colon cancer cell growth and spread by increasing anoikis.

Area Of Science

  • Oncology
  • Cell Biology
  • Genetics

Background

  • Anoikis, a form of programmed cell death, and mitophagy are crucial cellular processes.
  • Understanding genes regulating these processes is vital for cancer research.

Purpose Of The Study

  • To develop a prognostic model for colon cancer using anoikis and mitophagy-related genes (AMRGs).
  • To investigate the specific role of SPHK1 in colon cancer progression and anoikis.

Main Methods

  • Bioinformatic analysis to screen AMRGs.
  • LASSO regression for gene selection and prognostic model development.
  • In vitro experiments to assess SPHK1 function in colon cancer cells.

Main Results

  • A three-gene signature (SPHK1, CDC25C, VPS37A) was identified as a predictor of colon cancer survival.
  • Colon cancer subtypes and risk scores correlated with survival and immune cell infiltration.
  • Downregulated SPHK1 reduced colon cancer cell proliferation, migration, and invasion while enhancing anoikis.

Conclusions

  • The developed AMRGs risk score model shows promise for predicting colon cancer patient outcomes.
  • SPHK1 plays a significant role in inhibiting colon cancer cell growth and metastasis, potentially by promoting anoikis.

Related Concept Videos

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

PI3K/mTOR/AKT Signaling Pathway 01:22

3.4K

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...